New patent expiration for Novartis drug TRILEPTAL

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for TRILEPTAL
Annual Drug Patent Expirations for TRILEPTAL

Trileptal is a drug marketed by Novartis and is included in two NDAs. It is available from three suppliers. There is one patent protecting this drug and two Paragraph IV challenges.

TRILEPTAL drug price trends.

Drug patent litigation for TRILEPTAL.

The generic ingredient in TRILEPTAL is oxcarbazepine. Three suppliers are listed for this compound. Additional details are available on the oxcarbazepine profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top